• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于β-葡萄糖醛酸酶和碱性磷酸酶的HIV蛋白酶激活分子开关

HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase.

作者信息

O'Loughlin Taryn L, Matsumura Ichiro

机构信息

Department of Biochemistry, Center for Fundamental and Applied Molecular Evolution, Emory University School of Medicine, Rollins Research Center, Room 4119, 1510 Clifton Road, Atlanta, GA 30322, USA.

出版信息

Comb Chem High Throughput Screen. 2006 May;9(4):313-20. doi: 10.2174/138620706776843219.

DOI:10.2174/138620706776843219
PMID:16724922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2012946/
Abstract

Our long-term goal is to direct the evolution of novel protease variants. To this end we have engineered a new type of protease-activated reporter enzyme. Many protease-activated enzymes evolved in nature, but the introduction of novel regulatory mechanisms into normally unregulated enzymes poses a difficult design challenge. Random Elongation Mutagenesis [1] was used to fuse the p6 peptide, which is recognized and cleaved by HIV protease, and twelve random sequence amino acids to the C-termini of beta-glucuronidase (GUS) and alkaline phosphatase (AP). The resulting GUS-p6-(NNN)12 and AP-p6-(NNN)12 libraries were expressed in E. coli and screened for clones that were inactivated by the C-terminal extension (tail). The inactivated clones were co-expressed with HIV protease, and those that were re-activated were isolated. The AP and GUS activities of the most responsive clones were each >3.5-fold higher when co-expressed with HIV protease, and this activation is correlated with in vivo proteolysis. It should be possible to generalize this strategy to different reporter enzymes, different target proteases, and perhaps to other types of protein-modifying enzymes.

摘要

我们的长期目标是引导新型蛋白酶变体的进化。为此,我们设计了一种新型的蛋白酶激活报告酶。自然界中进化出了许多蛋白酶激活酶,但将新型调控机制引入通常无调控的酶中带来了艰巨的设计挑战。随机延伸诱变[1]被用于将可被HIV蛋白酶识别并切割的p6肽以及十二个随机序列氨基酸融合到β-葡萄糖醛酸酶(GUS)和碱性磷酸酶(AP)的C末端。所得的GUS-p6-(NNN)12和AP-p6-(NNN)12文库在大肠杆菌中表达,并筛选因C末端延伸(尾巴)而失活的克隆。将失活的克隆与HIV蛋白酶共表达,并分离出重新激活的克隆。与HIV蛋白酶共表达时,反应最灵敏的克隆的AP和GUS活性均高出>3.5倍,且这种激活与体内蛋白水解相关。将该策略推广到不同的报告酶、不同的靶蛋白酶,甚至可能推广到其他类型的蛋白质修饰酶应该是可行的。

相似文献

1
HIV protease-activated molecular switches based on beta-glucuronidase and alkaline phosphatase.基于β-葡萄糖醛酸酶和碱性磷酸酶的HIV蛋白酶激活分子开关
Comb Chem High Throughput Screen. 2006 May;9(4):313-20. doi: 10.2174/138620706776843219.
2
beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.
Proc Natl Acad Sci U S A. 1990 Dec;87(24):10023-7. doi: 10.1073/pnas.87.24.10023.
3
Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.人类免疫缺陷病毒1型感染的母婴中,HIV-1蛋白酶、Gag p7和p6以及gag/pol多蛋白内蛋白酶切割位点的自然变异:无蛋白酶抑制剂情况下的氨基酸替代
Virology. 1996 May 15;219(2):407-16. doi: 10.1006/viro.1996.0266.
4
Antibody-induced oligomerization and activation of an engineered reporter enzyme.抗体诱导的工程化报告酶的寡聚化和激活。
J Mol Biol. 2007 Jun 15;369(4):1052-9. doi: 10.1016/j.jmb.2007.03.076. Epub 2007 Apr 4.
5
HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.HIV-1 蛋白酶 N 端融合亮氨酸拉链后表现出增强的连接氨基酸依赖性活性。
Retrovirology. 2018 Apr 14;15(1):32. doi: 10.1186/s12977-018-0413-6.
6
[HIV-1 proteinase mutant with an altered region of the active center].[具有活性中心区域改变的HIV-1蛋白酶突变体]
Mol Biol (Mosk). 1998 Jul-Aug;32(4):678-85.
7
Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies.从包涵体中纯化和鉴定天然存在的HIV-1(南非C亚型)蛋白酶突变体。
Protein Expr Purif. 2016 Jun;122:90-6. doi: 10.1016/j.pep.2016.02.013. Epub 2016 Feb 23.
8
A rapid and simple screening method for HIV-1 protease inhibitors using recombinant Escherichia coli.一种使用重组大肠杆菌的快速简便的HIV-1蛋白酶抑制剂筛选方法。
J Antibiot (Tokyo). 1994 Apr;47(4):492-5. doi: 10.7164/antibiotics.47.492.
9
Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.基于大肠杆菌中环状AMP信号级联反应的蛋白酶活性灵敏遗传筛选。
J Bacteriol. 2000 Dec;182(24):7060-6. doi: 10.1128/JB.182.24.7060-7066.2000.
10
Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors.利用匹配的细菌表达载体和前病毒感染载体分析对1型人类免疫缺陷病毒蛋白酶抑制剂的耐药性。
J Virol. 1995 Sep;69(9):5431-6. doi: 10.1128/JVI.69.9.5431-5436.1995.

本文引用的文献

1
Creating small-molecule-dependent switches to modulate biological functions.创建小分子依赖性开关以调节生物学功能。
Chem Biol. 2005 Feb;12(2):151-61. doi: 10.1016/j.chembiol.2004.11.012.
2
A molecular switch created by in vitro recombination of nonhomologous genes.一种通过非同源基因体外重组产生的分子开关。
Chem Biol. 2004 Nov;11(11):1483-7. doi: 10.1016/j.chembiol.2004.08.020.
3
High throughput microplate screens for directed protein evolution.用于定向蛋白质进化的高通量微孔板筛选。
Methods Enzymol. 2004;388:134-45. doi: 10.1016/S0076-6879(04)88012-1.
4
Reprogramming control of an allosteric signaling switch through modular recombination.通过模块化重组对变构信号开关进行重编程控制。
Science. 2003 Sep 26;301(5641):1904-8. doi: 10.1126/science.1085945.
5
A comparison of directed evolution approaches using the beta-glucuronidase model system.使用β-葡萄糖醛酸酶模型系统对定向进化方法的比较。
J Mol Biol. 2003 Sep 26;332(4):851-60. doi: 10.1016/s0022-2836(03)00972-0.
6
Allosteric switching by mutually exclusive folding of protein domains.通过蛋白质结构域的互斥折叠实现变构转换。
J Mol Biol. 2003 Sep 19;332(3):529-36. doi: 10.1016/s0022-2836(03)00925-2.
7
HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization.来自100倍耐药临床分离株的HIV-1蛋白酶变体:表达、纯化及结晶
Protein Expr Purif. 2003 Mar;28(1):165-72. doi: 10.1016/s1046-5928(02)00650-2.
8
A yeast sensor of ligand binding.
Nat Biotechnol. 2001 Nov;19(11):1042-6. doi: 10.1038/nbt1101-1042.
9
Optimization of heterologous gene expression for in vitro evolution.
Biotechniques. 2001 Mar;30(3):474-6. doi: 10.2144/01303bm01.
10
Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.基于大肠杆菌中环状AMP信号级联反应的蛋白酶活性灵敏遗传筛选。
J Bacteriol. 2000 Dec;182(24):7060-6. doi: 10.1128/JB.182.24.7060-7066.2000.